04/25/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
04/23/2024
5:06 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/18/2024
3:31 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
04/18/2024
1:33 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC 13D | |
04/17/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
04/16/2024
4:07 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
04/15/2024
2:44 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
|
04/11/2024
5:01 AM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T | |
02/15/2024
3:15 PM | Novartis (Filer)
| Form S-8 POS | |
02/06/2024
3:52 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-C | |
02/05/2024
4:06 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-C | |
02/02/2024
1:18 PM | BlackRock Inc. (Filed by)
Novartis (Subject)
| Form SC 13G/A | |
01/31/2024
6:43 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/31/2024
6:43 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/31/2024
6:44 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/31/2024
6:44 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/31/2024
6:38 AM | Novartis (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
01/31/2024
6:42 AM | Novartis (Filer)
| Form IRANNOTICE | |
01/08/2024
5:13 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/11/2023
5:05 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/05/2023
7:19 PM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/28/2023
5:10 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/30/2023
5:05 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/24/2023
5:33 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/04/2023
5:57 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/02/2023
5:05 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/05/2023
5:10 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/21/2023
5:05 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/09/2023
5:05 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/18/2023
6:30 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/10/2023
3:08 PM | CHINOOK THERAPEUTICS, INC. (Subject)
CHINOOK THERAPEUTICS, INC. (Subject)
Novartis (Filed by)
| Form DFAN14A | |
07/10/2023
5:06 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/12/2023
8:26 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/12/2023
8:41 AM | CHINOOK THERAPEUTICS, INC. (Subject)
CHINOOK THERAPEUTICS, INC. (Subject)
Novartis (Filed by)
| Form DFAN14A | |
